Sarda Proteins achieved a significant turnaround in profitability during the quarter ended June 2026, reporting a standalone net profit of ₹165.97 lakh compared to a net loss of ₹49.34 lakh in the corresponding quarter of the previous financial year. According to the company's unaudited standalone financial results approved by the board on July 15, 2026, this represents a complete reversal in the company's financial performance, marking a substantial improvement in operational efficiency. The profit before tax stood at ₹221.30 lakh with a current tax expense of ₹55.33 lakh recorded for the period. The profit after tax grew by 161.92% sequentially from ₹84.49 lakh in Q4 FY26, demonstrating strong momentum in the company's strategic shift to higher-margin renewable energy products. The total comprehensive income settled at ₹165.97 lakh, with no adjustments reported under other comprehensive income, demonstrating the company's strong operational performance and successful strategic transformation in the renewable energy sector.
The company demonstrated strong revenue momentum with total revenue increasing to ₹1,847.40 lakh in Q1 FY27, representing a significant jump from ₹1,095.54 lakh recorded in the same quarter of the previous financial year. As reported in the unaudited standalone financial results, revenue from operations rose to ₹1,299.30 lakh from ₹1,095.46 lakh in Q1FY25, while other income surged to ₹548.10 lakh from just ₹0.08 lakh in the prior year quarter. This robust top-line growth indicates successful business expansion and improved market demand for the company's products. Sequential growth was even more impressive, with core revenues skyrocketing from a meager ₹65.00 lakh in Q4 FY26, highlighting the rapid commercial scaling following the company's strategic pivot into the renewable energy sector. The revenue from operations grew by 18.61% year-on-year, demonstrating the company's ability to capitalize on growing demand in the green energy sector.
The company's operating profit margin (OPM) improved significantly to -25.17% in the current quarter compared to -4.47% in the corresponding quarter of the previous year. According to the financial data, total expenses for the quarter were ₹1,626.10 lakh, compared to ₹1,144.88 lakh in Q1 FY26, reflecting the logistical and input costs associated with scaled-up product distribution. Purchase of Stock-in-Trade decreased to ₹970.32 lakh from ₹1,128.54 lakh in Q1 FY26, highlighting better sourcing optimization and lower raw material procurement drag. Employee Benefit Expenses stood at ₹12.15 lakh compared to ₹0.75 lakh in the year-ago period, while other expenses increased to ₹643.63 lakh against ₹15.59 lakh in Q1 FY26. Notably, the company reported nil finance costs and zero depreciation during the three-month period, demonstrating effective capital management. The operational expenditure increase of ₹481.12 lakh reflects the company's investment in scaling up its renewable energy operations and distribution capabilities.
Following its strategic pivot into a single-segment business model focusing entirely on the "Renewable Energy Sector Solar Cell Products", Sarda Proteins has unlocked rapid commercial scaling opportunities. The company's transition to higher-margin renewable energy products directly corrected the profitability curve, with the strategic shift enabling the company to capitalize on growing demand in the green energy sector. This business model transformation has positioned the company to benefit from the expanding renewable energy market, with the company reporting nil investor complaints received during the quarter and zero grievances pending resolution, significantly bolstering investor confidence alongside the robust financial results. The company's focus on solar cell products has enabled it to capitalize on the growing demand for renewable energy solutions, with the strategic shift directly contributing to the substantial profitability turnaround.
Reflecting the sharp earnings turnaround, basic and diluted Earnings Per Share (EPS) bounded back to a positive ₹1.85 per share (face value of ₹10 each), climbing from a negative EPS of ₹(2.86) in Q1 FY26 and ₹0.94 in Q4 FY26. The company's paid-up equity share capital stood at ₹89.759 lakh, expanding from ₹17.259 lakh in the year-ago quarter, indicating significant capital growth. The total comprehensive income settled at ₹165.97 lakh, with no adjustments reported under other comprehensive income, demonstrating the company's strong operational performance and successful strategic transformation in the renewable energy sector. However, the company has not been paying dividends despite reporting consistent profits, with dividend payout ratio remaining at 0% over the past year. The company's share capital expansion from ₹17.259 lakh to ₹89.759 lakh reflects the strong equity base supporting the business growth and the positive investor sentiment following the successful strategic pivot.
